Jennifer joined Immuneering as Associate Director, Clinical Scientist in 2026. She has over a decade of experience in oncology clinical trials, with prior experience as a Clinical Scientist on Phase I-III trials at Novartis, Celgene, and Regeneron. Jennifer also has site experience as a Research Pharmacist at Jacobi Medical Center and as a Study Coordinator at Dana-Farber Cancer Institute, as well as vendor experience in clinical trial technology products (mobile eCOA and EDC). Jennifer earned her PharmD from the University of Maryland School of Pharmacy and her B.A. in Child Development and Community Health from Tufts University.